Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 1,655 | 1,710 | 2,365 | 1,768 | 1,389 |
| Cost of Goods | 756 | 699 | 1,089 | 437 | 596 |
| Gross Profit | 898 | 1,010 | 1,276 | 1,331 | 793 |
| Operating Expenses | 4,198 | 3,802 | 3,944 | 4,371 | 4,415 |
| Operating Income | -2,543 | -2,093 | -2,578 | -2,603 | -3,027 |
| Interest Expense | 270 | 165 | 195 | 224 | 239 |
| Other Income | -11 | -27 | -2 | 84 | 77 |
| Pre-tax Income | -2,824 | -2,284 | -2,775 | -2,743 | -3,189 |
| Net Income Continuous | -2,824 | -2,284 | -2,775 | -2,743 | -3,189 |
| Net Income | $-2,824 | $-2,284 | $-2,775 | $-2,743 | $-3,189 |
| EPS Basic Total Ops | -0.04 | -0.03 | -0.04 | -0.04 | -0.05 |
| EPS Basic Continuous Ops | -0.04 | -0.03 | -0.04 | -0.04 | -0.05 |
| EPS Diluted Total Ops | -0.04 | -0.03 | -0.04 | -0.04 | -0.05 |
| EPS Diluted Continuous Ops | -0.04 | -0.03 | -0.04 | -0.04 | -0.05 |
| EBITDA(a) | $-2,372 | $-1,990 | $-2,470 | $-2,442 | $-2,900 |